When the world went into pandemic shock in early 2020, Indian smart document technology helped keep global vaccine research and approvals moving. The piece looks at how organisations in pharma & life sciences are replacing paper-bound agreements, approvals and records with secure, auditable digital workflows.
For teams that still print, sign, scan and courier documents, each agreement can take days. Every hand-off adds risk: version confusion, missing signatures and gaps in the audit trail that surface during inspections.
The challenge with paper-based workflows
Regulated businesses carry an extra burden. Every signature has to be attributable, every change traceable and every record retrievable for years. Manual processes make that expensive to prove.
- Long turnaround on contracts, SOPs and approvals
- No single source of truth for document versions
- Audit trails assembled by hand before each inspection
Digital signing is the first step. The larger gain comes from turning static files into smart documents that route, remind and record on their own.
How MSB Docs helps
MSB Docs combines legally binding eSignature with configurable document workflows. Templates, sequential and parallel routing, bulk send and role-based access let teams move a document from draft to signed record without leaving the platform.
For life sciences customers, signing ceremonies, signature manifestation and tamper-evident audit trails support 21 CFR Part 11 and EU Annex 11 expectations. Deployment options include cloud and on-premise to meet data residency rules.
What comes next
As more industries digitise, the focus is shifting from signing to the full document lifecycle: creation, collaboration, approval and long-term retention. MSB Docs continues to invest in that lifecycle across India, the US and the Middle East.
